The ALKConnect Patient Registry is closed.

Thank you for your interest and/or contribution to patient-informed research in ALK+ NSCLC. The study has come to a close, but that does not mean work in ALK+ NSCLC is done. Takeda is closing ALKConnect to pursue other avenues of research in ALK+ NSCLC and the company looks forward to continued progress.

Responses obtained through this study will be analyzed and published.